These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23205928)

  • 1. Ranolazine maintained sinus rhythm in a patient with refractory symptomatic atrial fibrillation.
    Sossalla S; Sohns C; Seegers J; Lüthje L; Vollmann D; Zabel M
    Cardiovasc Ther; 2013 Oct; 31(5):303-6. PubMed ID: 23205928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ranolazine enhances the efficacy of amiodarone for conversion of recent-onset atrial fibrillation.
    Koskinas KC; Fragakis N; Katritsis D; Skeberis V; Vassilikos V
    Europace; 2014 Jul; 16(7):973-9. PubMed ID: 24473502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspective: does ranolazine have potential for the treatment of atrial fibrillation?
    Hancox JC; Doggrell SA
    Expert Opin Investig Drugs; 2010 Dec; 19(12):1465-74. PubMed ID: 21105855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic properties of ranolazine--from bench to bedside.
    Tzeis S; Andrikopoulos G
    Expert Opin Investig Drugs; 2012 Nov; 21(11):1733-41. PubMed ID: 22916846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ranolazine as a promising treatment option for atrial fibrillation: electrophysiologic mechanisms, experimental evidence, and clinical implications.
    Fragakis N; Koskinas KC; Vassilikos V
    Pacing Clin Electrophysiol; 2014 Oct; 37(10):1412-20. PubMed ID: 25138058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium channel block by ranolazine in an experimental model of stretch-related atrial fibrillation: prolongation of interatrial conduction time and increase in post-repolarization refractoriness.
    Milberg P; Frommeyer G; Ghezelbash S; Rajamani S; Osada N; Razvan R; Belardinelli L; Breithardt G; Eckardt L
    Europace; 2013 May; 15(5):761-9. PubMed ID: 23376977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrapericardial ranolazine prolongs atrial refractory period and markedly reduces atrial fibrillation inducibility in the intact porcine heart.
    Carvas M; Nascimento BC; Acar M; Nearing BD; Belardinelli L; Verrier RL
    J Cardiovasc Pharmacol; 2010 Mar; 55(3):286-91. PubMed ID: 20075744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranolazine for the prevention or treatment of atrial fibrillation: a systematic review.
    Dagres N; Iliodromitis EK; Lekakis JP; Simitsis P; Karatzas D; Rallidis LS; Simeonidou E; Anastasiou-Nana M
    J Cardiovasc Med (Hagerstown); 2014 Mar; 15(3):254-9. PubMed ID: 24662415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of ranolazine for rhythm control in an elderly patient with paroxysmal atrial fibrillation.
    Santillo E; Migale M; Postacchini D; Fallavollita L; Marini L; Balestrini F
    Clin Ter; 2014; 165(2):e166-9. PubMed ID: 24770828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential application of late sodium current blockade in the treatment of heart failure and atrial fibrillation.
    Doshi D; Morrow JP
    Rev Cardiovasc Med; 2009; 10 Suppl 1():S46-52. PubMed ID: 19898288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ranolazine safely decreases ventricular and atrial fibrillation in Timothy syndrome (LQT8).
    Shah DP; Baez-Escudero JL; Weisberg IL; Beshai JF; Burke MC
    Pacing Clin Electrophysiol; 2012 Mar; 35(3):e62-4. PubMed ID: 20883512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New antiarrhythmic drugs for treatment of atrial fibrillation.
    Dobrev D; Nattel S
    Lancet; 2010 Apr; 375(9721):1212-23. PubMed ID: 20334907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic efficacy of azimilide in patients with atrial fibrillation. Maintenance of sinus rhythm after conversion to sinus rhythm.
    Pritchett EL; Kowey P; Connolly S; Page RL; Kerr C; Wilkinson WE;
    Am Heart J; 2006 May; 151(5):1043-9. PubMed ID: 16644334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antiarrhythmic effects of ranolazine.
    Foster NJ; Haines DE
    Rev Cardiovasc Med; 2009; 10 Suppl 1():S38-45. PubMed ID: 19898287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ranolazine--an additional anti-anginal drug].
    Michels G; Kochanek M; Hoppe UC
    Dtsch Med Wochenschr; 2010 Oct; 135(41):2037-40. PubMed ID: 20925013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ranolazine exerts potent effects on atrial electrical properties and abbreviates atrial fibrillation duration in the intact porcine heart.
    Kumar K; Nearing BD; Carvas M; Nascimento BC; Acar M; Belardinelli L; Verrier RL
    J Cardiovasc Electrophysiol; 2009 Jul; 20(7):796-802. PubMed ID: 19298570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination use of ranolazine with dofetilide for the maintenance of atrial fibrillation.
    Shah SA; Koyama G; Da Costa D; McGregor P; Kolasa M
    Int J Cardiol; 2014 Apr; 172(3):e428-9. PubMed ID: 24461967
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of ranolazine in the prevention and treatment of postoperative atrial fibrillation in patients undergoing cardiac surgery.
    Tsu LV; Lee S
    Ann Pharmacother; 2014 May; 48(5):633-7. PubMed ID: 24523397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks.
    Bunch TJ; Mahapatra S; Murdock D; Molden J; Weiss JP; May HT; Bair TL; Mader KM; Crandall BG; Day JD; Osborn JS; Muhlestein JB; Lappe DL; Anderson JL
    Pacing Clin Electrophysiol; 2011 Dec; 34(12):1600-6. PubMed ID: 21895727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A focus on antiarrhythmic properties of ranolazine.
    Vizzardi E; D'Aloia A; Quinzani F; Bonadei I; Rovetta R; Bontempi L; Curnis A; Dei Cas L
    J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):353-6. PubMed ID: 22492919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.